Annual Operating Expenses
$143.52 M
+$25.22 M+21.32%
December 31, 2023
Summary
- As of February 10, 2025, CALT annual total operating expenses is $143.52 million, with the most recent change of +$25.22 million (+21.32%) on December 31, 2023.
- During the last 3 years, CALT annual operating expenses has risen by +$101.67 million (+242.97%).
Performance
CALT Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Operating Expenses
$50.42 M
+$3.63 M+7.76%
June 30, 2024
Summary
- As of February 10, 2025, CALT quarterly total operating expenses is $50.42 million, with the most recent change of +$3.63 million (+7.76%) on June 30, 2024.
- Over the past year, CALT quarterly operating expenses has increased by +$3.63 million (+7.76%).
Performance
CALT Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
CALT Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +21.3% | +7.8% |
| 3 y3 years | +243.0% | +82.4% |
| 5 y5 years | +855.3% | +801.0% |
CALT Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -39.1% | at high | -45.2% |
| 5 y | 5-year | at high | -84.3% | at high | -86.7% |
| alltime | all time | at high | -95.8% | at high | -97.6% |
Calliditas Therapeutics AB (Publ) Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $50.42 M(+7.8%) |
| Mar 2024 | - | $46.79 M(+17.2%) |
| Dec 2023 | $143.52 M(+21.3%) | $39.92 M(-2.0%) |
| Sep 2023 | - | $40.72 M(+29.5%) |
| Jun 2023 | - | $31.44 M(-9.6%) |
| Mar 2023 | - | $34.77 M(+1.6%) |
| Dec 2022 | $118.30 M(+35.4%) | $34.23 M(+22.9%) |
| Sep 2022 | - | $27.85 M(+0.4%) |
| Jun 2022 | - | $27.75 M(+0.4%) |
| Mar 2022 | - | $27.64 M(-1.3%) |
| Dec 2021 | $87.36 M(+108.8%) | $27.99 M(+27.0%) |
| Sep 2021 | - | $22.04 M(+16.2%) |
| Jun 2021 | - | $18.96 M(+5.3%) |
| Mar 2021 | - | $18.01 M(+11.5%) |
| Dec 2020 | $41.85 M | $16.15 M(+36.3%) |
| Sep 2020 | - | $11.85 M(+72.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $6.89 M(-9.0%) |
| Mar 2020 | - | $7.57 M(+12.7%) |
| Dec 2019 | $22.52 M(+49.9%) | $6.72 M(+22.3%) |
| Sep 2019 | - | $5.49 M(-1.9%) |
| Jun 2019 | - | $5.60 M(+20.0%) |
| Mar 2019 | - | $4.66 M(-1.1%) |
| Dec 2018 | $15.02 M(+51.2%) | $4.71 M(+34.8%) |
| Sep 2018 | - | $3.50 M(+66.2%) |
| Jun 2018 | - | $2.10 M(-55.4%) |
| Mar 2018 | - | $4.72 M(-3.4%) |
| Dec 2017 | $9.93 M(+50.2%) | $4.89 M(+127.4%) |
| Sep 2017 | - | $2.15 M(+22.2%) |
| Jun 2017 | - | $1.76 M(+42.6%) |
| Mar 2017 | - | $1.23 M |
| Dec 2016 | $6.61 M(+8.5%) | - |
| Dec 2015 | $6.10 M | - |
FAQ
- What is Calliditas Therapeutics AB (publ) annual total operating expenses?
- What is the all time high annual operating expenses for Calliditas Therapeutics AB (publ)?
- What is Calliditas Therapeutics AB (publ) annual operating expenses year-on-year change?
- What is Calliditas Therapeutics AB (publ) quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Calliditas Therapeutics AB (publ)?
- What is Calliditas Therapeutics AB (publ) quarterly operating expenses year-on-year change?
What is Calliditas Therapeutics AB (publ) annual total operating expenses?
The current annual operating expenses of CALT is $143.52 M
What is the all time high annual operating expenses for Calliditas Therapeutics AB (publ)?
Calliditas Therapeutics AB (publ) all-time high annual total operating expenses is $143.52 M
What is Calliditas Therapeutics AB (publ) annual operating expenses year-on-year change?
Over the past year, CALT annual total operating expenses has changed by +$25.22 M (+21.32%)
What is Calliditas Therapeutics AB (publ) quarterly total operating expenses?
The current quarterly operating expenses of CALT is $50.42 M
What is the all time high quarterly operating expenses for Calliditas Therapeutics AB (publ)?
Calliditas Therapeutics AB (publ) all-time high quarterly total operating expenses is $50.42 M
What is Calliditas Therapeutics AB (publ) quarterly operating expenses year-on-year change?
Over the past year, CALT quarterly total operating expenses has changed by +$3.63 M (+7.76%)